Epizyme Inc Shares Fall 1.5% Below Previous 52-Week Low - Market Mover
The shares fell 1.5% lower than its previous 52-week low of $2.59, with trading volume lower than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Epizyme Inc (EPZM) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $270M. The stock is currently down 76.1% year-to-date, down 77.9% over the past 12 months, and down 78.6% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%.
Trading Activity
- Trading volume this week was 57.1% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Epizyme Inc | -1.9 | -76.1 | -77.9 | -79.8 | -1.2 |
| Dow Jones Industrial Average | 0.2 | 21.0 | 21.8 | -0.3 | 23.9 |
| S&P 500 Index | 0.1 | 29.2 | 29.8 | -0.4 | 32.5 |
| Health Care | 0.6 | 23.0 | 24.6 | -0.8 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -690.1%
- The company's stock price performance over the past 12 months lags the peer average by -739.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Epizyme Inc | EPZM | 0 | -76.1 | -77.9 | -79.8 | -1.2 |
| Peer Avg | N/A | 0.4 | 12.9 | 12.2 | -22.5 | 24.2 |
| Abbott Laboratories | ABT | 34.3 | 30.3 | 32.3 | -1.5 | 34.3 |
| Novartis AG - ADR | NVS | 37.2 | -2.9 | 0.5 | -7.8 | 10.5 |
| Glaxosmithkline plc - ADR | GSK | 17.1 | 26.8 | 28.6 | -0.0 | 36.8 |
| Seagen Inc | SGEN | -86.6 | -10.0 | -15.2 | -20.5 | 18.7 |
| Bio-Path Holdings Inc | BPTH | 0 | 20.3 | 14.7 | -82.8 | 20.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: